Headline News about Gilead SciencesVia Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today
February 23, 2024
Via Benzinga
Via Talk Markets
Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Topics
Stocks
Exposures
US Equities
Via Benzinga
Drugmaker Gilead Sciences Scoops Up Liver-Disease Focused CymaBay Therapeutics For $4.3B
February 12, 2024
Via Benzinga
Exposures
Product Safety
Gilead Sciences Stock Approaches Daily Buying Area
February 12, 2024
Via Talk Markets
Exposures
COVID-19
Gilead-Backed Kyverna Overshoots Raised IPO Expectations
February 11, 2024
Via Talk Markets
Topics
Initial Public Offering
Exposures
Securities Market
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|